The Immune-Modulator Pidotimod Affects the Metabolic Profile of Exhaled Breath Condensate in Bronchiectatic Patients: A Metabolomics Pilot Study

• Main Authors: Maria D'Amato (Author), Debora Paris (Author), Antonio Molino (Author), Paola Cuomo (Author), Andrea Fulgione (Author), Nunzia Sorrentino (Author), Letizia Palomba (Author), Mauro Maniscalco (Author), Andrea Motta (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Pidotimod, a synthetic dipeptide molecule with biological and immunological activities, is used to reduce the number of exacerbations or pneumonitis in patients with inflammatory diseases.In the present study, we investigated whether Pidotimod modifies the metabolomic pathways measured...